evipedia.ai
← Back

Saw Palmetto for Health & Longevity

Created on 11/02/2026 – Quick Reference based on Evidence Review created using AI4L / Opus 5.5 – Audit

Saw palmetto, a berry extract sold as a plant supplement, is taken mainly by older men for urinary symptoms from an enlarged prostate and by men and women for thinning hair. The largest independent trials found it no better than placebo for urinary symptoms; hair gains rest on small maker-linked studies. Side effects in trials match placebo rates; rare reports of liver injury, pancreas inflammation and bleeding remain unconfirmed. (Full Review)

Protocol

Standard dose (urinary symptoms)
320 mg daily
Lipidosterolic (fat-and-sterol) extract, as 160 mg twice daily or 320 mg once daily
Hair-loss dosing
160 or 320 mg daily
320 mg in a 2-year comparison with finasteride; one 160 mg softgel of proprietary extract in the 6-month placebo-controlled trial
Time of day
Any time, with a meal
Meal containing fat, because the extract is fat-soluble (common practice)
Time to effect
Hair regrowth in thinning hair
90–180 days
Hair counts versus placebo in a 6-month trial
Less bleeding during prostate surgery
About 2 months
Permixon pretreatment before prostate surgery
Chronic prostatitis and pelvic pain relief
2 weeks
Pain scores separated from placebo in one trial

Benefits

Contraindications
  • Pregnant or breastfeeding women
  • Women and children generally
  • People within 2 weeks of elective surgery
  • People with prior saw palmetto–associated liver injury or pancreatitis
  • Men with new urinary symptoms not yet medically evaluated
    •
Key Interactions
  • Anticoagulants and antiplatelets (warfarin, aspirin): possible increased bleeding
  • Stinging nettle root (supplement): combination tested; additivity is untested
    •
Theoretical (inferred from mechanism)
  • Over-the-counter NSAIDs (ibuprofen, naproxen): possible additive stomach irritation and bleeding
  • 5-alpha reductase inhibitors (finasteride, dutasteride): possible additive antiandrogenic effects
  • Hormonal contraceptives and estrogen therapy (ethinylestradiol, estradiol): possible altered hormonal effect
  • Testosterone therapy (testosterone cypionate, testosterone gel): possibly reduced DHT conversion
  • CYP2C9 and UGT substrates (warfarin, lorazepam): possibly raised drug levels
  • Bleeding-prone supplements (fish oil, ginkgo): possible additive bleeding tendency
  • Other prostate botanicals (pygeum, β-sitosterol): possible additive urinary effects
    •

Risk & Side Effects

  • High:
  • Medium:
  • Low: Mild gastrointestinal symptoms and headache; bleeding, including during surgery; liver injury; acute pancreatitis; rhabdomyolysis; reduced libido and sexual dysfunction; persistent sexual and neuropsychiatric symptoms after stopping
    •
  • Speculative: Fetal effects in pregnancy; delayed prostate cancer diagnosis
    •

Monitoring

Marker Target Why
IPSS No established target; track change from own baseline Primary benefit marker
PSA 0–4.0 ng/mL (standard reference range) Safety check: rise changes use
ALT 7–56 U/L (standard reference range) Safety check: rise stops use
Bilirubin Not specified in the ER Paired with ALT to detect liver injury with blocked bile flow
Alkaline phosphatase Not specified in the ER Paired with ALT to detect liver injury with blocked bile flow
INR (warfarin users only) No established target for saw palmetto; track against the prescriber's warfarin range Safety check: rise changes use

Cadence: Baseline medical evaluation, PSA, symptom questionnaire and, for hair use, scalp photographs; symptom score at 3 months, then every 6–12 months; PSA every 12 months; liver enzymes at 3 months with liver risk and at any symptom of liver injury; INR 1–2 weeks after starting or stopping alongside warfarin; hair photographs at 6 and 12 months

Qualitative Assessment

  • Night-time voids and daytime urinary frequency
  • Urinary stream strength, urgency and sense of complete emptying
  • Hair shedding and density in standardized photographs
  • Libido and erectile and ejaculatory function
  • Mood, anxiety and sleep changes, including after stopping
  • Digestive comfort (abdominal pain, nausea)
  • Unusual bruising, bleeding gums or blood in urine
  • Yellowing of the skin or eyes, dark urine or itching
Not medical advice. Educational distillation of a single evidence review. Confirm any decision with a qualified clinician, especially in the presence of prescription drugs or chronic conditions.